Targeting hypothalamic SIK3 to promote weight loss and improve glycemic control in mice.

Saved in:
Bibliographic Details
Title: Targeting hypothalamic SIK3 to promote weight loss and improve glycemic control in mice.
Authors: Onda DA; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Yang CH; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Goldsmith C; Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria, Australia., Beddows CA; Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria, Australia., Teo RQ; Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria, Australia., Zhang L; St Vincent's Center for Applied Medical Research, Sydney, NSW, Australia., Yuan X; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Zhu Y; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Lee MK; Division of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, Australia., Ovens AJ; Protein Engineering in Immunity & Metabolism, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Yu D; St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Sakamoto K; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark., Scott JW; St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Melbourne, Victoria, Australia., Murphy AJ; Division of Immunometabolism, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Diabetes, Monash University, Melbourne, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia., Tsumaki N; Department of Tissue Biochemistry, Graduate School of Medicine and Frontier Biosciences, Osaka University, Osaka, Japan., Herzog H; St Vincent's Center for Applied Medical Research, Sydney, NSW, Australia., Dodd GT; Department of Anatomy and Physiology, The University of Melbourne, Melbourne, Victoria, Australia., Loh K; Diabetes and Metabolic Disease, St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia. kloh@svi.edu.au.; Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia. kloh@svi.edu.au.; Mary MacKillop Institute for Health Research, Australian Catholic University, Victoria, Australia. kloh@svi.edu.au.
Source: Nature communications [Nat Commun] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-026-73649-1